| 1 |
The mutational constraint spectrum quantified from variation in 141,456 humans
Konrad J. Karczewski et al. · Nature
Open access177 authors |
27 May 2020 |
10,422 |
| 2 |
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta, Daniel Francis McAuley, Michael Brown et al. · The Lancet
Open access |
Mar 2020 |
10,244 |
| 3 |
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al. · New England Journal of Medicine
Open access |
7 Mar 2012 |
7,931 |
| 4 |
Inflammation and cancer: back to Virchow?
Frances R. Balkwill, Alberto Mantovani · The Lancet
|
Feb 2001 |
7,766 |
| 5 |
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Andrew Rhodes et al. · Intensive Care Medicine
Open access |
18 Jan 2017 |
6,868 |
| 6 |
The socio-economic implications of the coronavirus pandemic (COVID-19): A review
Maria Nicola, Zaid Alsafi, Catrin Sohrabi et al. · International Journal of Surgery
Open access |
16 Apr 2020 |
6,554 |
| 7 |
World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)
Catrin Sohrabi, Zaid Alsafi, Niamh O’Neill et al. · International Journal of Surgery
Open access |
26 Feb 2020 |
6,329 |
| 8 |
The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines
Riaz Agha et al. · International Journal of Surgery
Open access |
9 Nov 2020 |
5,605 |
| 9 |
MEASUREMENT OF PAIN
E.C. HUSKISSON · The Lancet
|
Nov 1974 |
4,523 |
| 10 |
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Rita Alaggio et al. · Leukemia
Open access |
22 Jun 2022 |
4,010 |
| 11 |
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al. · The Lancet
Open access |
5 Mar 2016 |
3,762 |
| 12 |
J Antimicrob Chemother 1994; 33: 350–351
Elizabeth M. O’Shaughnessy, SATYA S. DAS · Journal of Antimicrobial Chemotherapy
|
1994 |
3,753 |
| 13 |
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I. Rini et al. · New England Journal of Medicine
Open access |
16 Feb 2019 |
3,488 |
| 14 |
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
Börje Ljungberg, Karim Bensalah, Steven E. Canfield et al. · European Urology
Open access |
21 Jan 2015 |
3,474 |
| 15 |
DNA methylation-based classification of central nervous system tumours
David Capper et al. · Nature
Open access143 authors |
13 Mar 2018 |
3,228 |
| 16 |
Effects of Torcetrapib in Patients at High Risk for Coronary Events
Philip J. Barter, Mark J. Caulfield, Mats A. L. Eriksson et al. · New England Journal of Medicine
Open access |
5 Nov 2007 |
3,168 |
| 17 |
Wireless capsule endoscopy
Gavriel J. Iddan, Gavriel Meron, Arkady Glukhovsky et al. · Nature
|
25 May 2000 |
3,074 |
| 18 |
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
Janine Bestall, ELIZABETH A. PAUL, R. Garrod et al. · Thorax
Open access |
Jul 1999 |
2,976 |
| 19 |
Controlled Sedation with Alphaxalone-Alphadolone
Michael A. E. Ramsay, T.M. Savege, B. R. J. Simpson et al. · BMJ
Open access |
22 Jun 1974 |
2,925 |
| 20 |
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Matthew J. Maurer et al. · New England Journal of Medicine
Open access |
27 Aug 2018 |
2,841 |
| 21 |
Graphic representation of pain
Jane Scott, E.C. HUSKISSON · Pain
|
Jun 1976 |
2,730 |
| 22 |
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
Christina Fitzmaurice et al. · JAMA Oncology
Open access628 authors |
27 Sep 2019 |
2,699 |
| 23 |
Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma
Paul Gerard Guy Richardson et al. · New England Journal of Medicine
Open access |
15 Jun 2005 |
2,514 |
| 24 |
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
Margaret Ann Shipp, Ken N. Ross, Pablo Tamayo et al. · Nature Medicine
|
2002 |
2,460 |
| 25 |
Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis
John Allotey et al. · BMJ
ReviewOpen access |
Sep 2020 |
2,402 |
| 26 |
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
Christopher Andrew Lamb et al. · Gut
Open access |
27 Sep 2019 |
2,370 |
| 27 |
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
TERENCE A. R. SEEMUNGAL, Gavin C. Donaldson, ELIZABETH A. PAUL et al. · American Journal of Respiratory and Critical Care Medicine
|
May 1998 |
2,344 |
| 28 |
The SCARE 2018 statement: Updating consensus Surgical CAse REport (SCARE) guidelines
Riaz Agha et al. · International Journal of Surgery
Open access |
18 Oct 2018 |
2,340 |
| 29 |
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
Gavin C. Donaldson · Thorax
Open access |
25 Sep 2002 |
2,304 |
| 30 |
Listening to silence and understanding nonsense: exonic mutations that affect splicing
Luca Cartegni, Shern L. Chew, Adrian R. Krainer · Nature Reviews Genetics
Review |
Apr 2002 |
2,237 |
| 31 |
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
Arjun Vasant Balar et al. · The Lancet
Open access |
7 Dec 2016 |
2,230 |
| 32 |
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
John Patrick Thornhill et al. · New England Journal of Medicine
Open access |
21 Jul 2022 |
2,219 |
| 33 |
Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults
Chris Frerk, Viki Mitchell, Alistair F. McNarry et al. · British Journal of Anaesthesia
Open access |
10 Nov 2015 |
2,218 |
| 34 |
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Eleftheria Zeggini et al. · Science
Open access |
26 Apr 2007 |
2,218 |
| 35 |
Multiple sclerosis – a review
Ruth Dobson, Gavin Giovannoni · European Journal of Neurology
Open access |
10 Oct 2018 |
2,167 |
| 36 |
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollón et al. · Journal of Crohn s and Colitis
Open access |
22 Sep 2016 |
2,100 |
| 37 |
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
David J. Grimwade, Robert K. Hills, Anthony V. Moorman et al. · Blood
Open access |
12 Apr 2010 |
1,972 |
| 38 |
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial
Sheena McCormack et al. · The Lancet
Open access |
11 Sep 2015 |
1,919 |
| 39 |
Regulatory Functions of the Vascular Endothelium
Franklin H. Epstein, John Robert Vane, Erik Änggård et al. · New England Journal of Medicine
|
5 Jul 1990 |
1,902 |
| 40 |
A simple method of reducing the fading of immunofluorescence during microscopy
G. Dana Johnson, Gloria M. de C. Nogueira Araujo · Journal of Immunological Methods
|
Jun 1981 |
1,886 |
| 41 |
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes
Eleftheria Zeggini et al. · Nature Genetics
ReviewOpen access |
30 Mar 2008 |
1,880 |
| 42 |
Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer
Hans von der Maase, Lisa Sengeløv, James T. Roberts et al. · Journal of Clinical Oncology
|
20 Jul 2005 |
1,870 |
| 43 |
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
Christian Maaser et al. · Journal of Crohn s and Colitis
Open access |
17 Aug 2018 |
1,868 |
| 44 |
Stromal Gene Signatures in Large-B-Cell Lymphomas
Georg Lenz et al. · New England Journal of Medicine
Open access |
26 Nov 2008 |
1,851 |
| 45 |
beta-Lactamases in laboratory and clinical resistance
David M. Livermore · Clinical Microbiology Reviews
Open access |
Oct 1995 |
1,744 |
| 46 |
Acute Traumatic Coagulopathy
Karim Brohi, Jasmin Singh, Mischa Heron et al. · The Journal of Trauma: Injury, Infection, and Critical Care
|
Jun 2003 |
1,737 |
| 47 |
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
Robert Louis Coleman et al. · The Lancet
Open access117 authors |
12 Sep 2017 |
1,729 |
| 48 |
Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.
Jane A. Mitchell, Pravit Akarasereenont, Christoph Thiemermann et al. · Proceedings of the National Academy of Sciences
Open access |
15 Dec 1993 |
1,671 |
| 49 |
A classification of fistula-in-ano
Alan G Parks, P H Gordon, J D Hardcastle · British journal of surgery
|
1976 |
1,665 |
| 50 |
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.
Tim A. Lister, D. Crowther, S.B. Sutcliffe et al. · Journal of Clinical Oncology
|
Nov 1989 |
1,640 |